RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vivek Kashyap to Animals

This is a "connection" page, showing publications Vivek Kashyap has written about Animals.
Connection Strength

0.229
  1. Kashyap VK, Sharma BP, Pandey D, Singh AK, Peasah-Darkwah G, Singh B, Roy KK, Yallapu MM, Chauhan SC. Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis. Cells. 2024 12 12; 13(24).
    View in: PubMed
    Score: 0.066
  2. Kaur R, Gupta S, Tripathi V, Chauhan A, Parashar D, Shankar P, Kashyap V. Microbiome based approaches for the degradation of polycyclic aromatic hydrocarbons (PAHs): A current perception. Chemosphere. 2023 Nov; 341:139951.
    View in: PubMed
    Score: 0.060
  3. Kashyap VK, Dan N, Chauhan N, Wang Q, Setua S, Nagesh PKB, Malik S, Batra V, Yallapu MM, Miller DD, Li W, Hafeez BB, Jaggi M, Chauhan SC. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Lett. 2020 02 01; 470:64-74.
    View in: PubMed
    Score: 0.046
  4. Yadav R, Chaudhary AA, Srivastava U, Gupta S, Rustagi S, Rudayni HA, Kashyap VK, Kumar S. Mpox 2022 to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment. Viruses. 2025 05 25; 17(6).
    View in: PubMed
    Score: 0.017
  5. Kotnala S, Dhasmana A, Kashyap VK, Chauhan SC, Yallapu MM, Jaggi M. A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder. Life Sci. 2021 Mar 01; 268:118959.
    View in: PubMed
    Score: 0.012
  6. Nagesh PKB, Chowdhury P, Hatami E, Kumari S, Kashyap VK, Tripathi MK, Wagh S, Meibohm B, Chauhan SC, Jaggi M, Yallapu MM. Cross-Linked Polyphenol-Based Drug Nano-Self-Assemblies Engineered to Blockade Prostate Cancer Senescence. ACS Appl Mater Interfaces. 2019 Oct 23; 11(42):38537-38554.
    View in: PubMed
    Score: 0.011
  7. Singh S, Roy KK, Khan SR, Kashyap VK, Sharma A, Jaiswal S, Sharma SK, Krishnan MY, Chaturvedi V, Lal J, Sinha S, Dasgupta A, Gupta AD, Srivastava R, Saxena AK. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Bioorg Med Chem. 2015 Feb 15; 23(4):742-52.
    View in: PubMed
    Score: 0.008
  8. Saxena AK, Roy KK, Singh S, Vishnoi SP, Kumar A, Kashyap VK, Kremer L, Srivastava R, Srivastava BS. Identification and characterisation of small-molecule inhibitors of Rv3097c-encoded lipase (LipY) of Mycobacterium tuberculosis that selectively inhibit growth of bacilli in hypoxia. Int J Antimicrob Agents. 2013 Jul; 42(1):27-35.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support